Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 10/20 | 0.63 |
| ▸ | FAAH | O00519 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.63 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.63 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | XBP1 | P17861 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.63 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4589798 | 1.00 | MGLL (0.63) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL4589431 | 0.92 | MGLL (0.58) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL18952969 | 0.84 | MGLL (0.50) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL26107057 | 0.82 | MGLL (0.37) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL1985393 | 0.82 | MGLL (0.37) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL3616721 | 0.82 | MGLL (0.77) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL18350795 | 0.81 | MGLL (0.59) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL16060512 | 0.81 | MGLL (0.59) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL258626 | 0.79 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL818349 | 0.79 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683972-A1 | SILICON PHTHALOCYANINE AND TRIBENZOPHTHALOCYANINE DYES AND THEIR USE IN DIAGNOSIS AND THERAPY | Albert-Ludwigs-Universität Freiburg (DE) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024194415-A1 | SILICON PHTHALOCYANINE AND TRIBENZOPHTHALOCYANINE DYES AND THEIR USE IN DIAGNOSIS AND THERAPY | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2024-09-26 | — | — | WO | disclosed |
| EP-4435060-A1 | SILICON PHTHALOCYANINE AND TRIBENZOPHTHALOCYANINE DYES AND THEIR USE IN DIAGNOSIS AND THERAPY | Albert-Ludwigs-Universität Freiburg (DE) | 2024-09-25 | — | — | EP | disclosed |
| US-11572379-B2 | Monomaleimide-functionalized platinum compounds for cancer therapy | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2023-02-07 | — | — | US | disclosed |
| US-11572379-B2 | Monomaleimide-functionalized platinum compounds for cancer therapy | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2023-02-07 | — | — | US | disclosed |
| CN-108368143-B | Monomaleimide functionalized platinum compounds for cancer therapy | 维也纳医科大学 | 2022-02-01 | — | — | CN | disclosed |
| US-20210228530-A1 | TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF | SANTOLECAN PHARMACEUTICALS LLC | 2021-07-29 | — | — | US | disclosed |
| EP-3386997-B1 | MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY | UNIV WIEN MED (AT) | 2021-06-30 | — | — | EP | disclosed |
| EP-3386997-B1 | MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY | UNIV WIEN MED (AT) | 2021-06-30 | — | — | EP | disclosed |
| EP-3157515-B1 | PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF | PLACON THERAPEUTICS INC (US) | 2021-05-26 | — | — | EP | disclosed |
| WO-2004101550-A1 | OXETANE COMPOUNDS CONTAINING MALEIMIDE FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101646-A1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225074-A1 | Adhesive compositions containing hybrid oxetane compounds | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| EP-0888389-B1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SURMODICS INC (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2004012735-A2 | NEW EFFECTOR CONJUGATES, PROCESS FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE | SCHERING AG (DE) | 2004-02-12 | — | — | WO | disclosed |
| EP-0888389-A4 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SURMODICS INC (US) | 2001-03-14 | — | — | EP | disclosed |
| US-5942555-A | Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom | SURMODICS, INC. (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0888389-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SurModics, Inc. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034935-A1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | BSI CORPORATION (US) | 1997-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228530-A1 | TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF | DDOST, UGT2B17, UGT1A7 | MGLL 1285/4885FAAH 2384/4885ALDH1A1 345/4885 |
| US-11572379-B2 | Monomaleimide-functionalized platinum compounds for cancer therapy | FOLR2, FOLR1, SLC19A1 | MGLL 3581/4885FAAH 3461/4885ALDH1A1 982/4885 |
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | OXGR1, DUOX2, JMJD6 | MGLL 3680/4885FAAH 870/4885ALDH1A1 2841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.